|
1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013 Jan; 63(1): 11-30. doi:10.3322/caac.21166 2. Forouzandeh F, Salimi S, Naghsh N, Zamani N, Jahani S. [Evaluation of anti-cancer effect of Peganum harmala L hydroalcholic extract on human cervical carcinoma epithelial cell line]. J Shahrekord Univ Med Sci. 2014; 16(4): 1-8. [Article in Persian] 3. Bastani S, Mohamadzade M, Pazhang Y. [The anti-proliferative and apoptotic effects of propranolol on K562 cell line]. Armaghane-danesh. 2016; 20(12): 1119-29. [Article in Persian] 4. Machado Ximenes JC, Lima Verde EC, Naffah-Mazzacoratti MG, Barros Viana GS. Valproic acid, a drug with multiple molecular targets related to its potential neuroprotective action. Neuroscience and Medicine. 2012 Mar; 3(1): 107-23. doi:10.4236/nm.2012.31016 5. Kostrouchová M, Kostrouch Z, Kostrouchová M. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol (Praha). 2007; 53(2): 37-49. 6. Blaheta RA, Michaelis M, Driever PH, Cinatl J Jr. Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med Res Rev. 2005 Jul; 25(4): 383-97. doi:10.1002/med.20027 7. Kwiecinska P, Taubøll E, Gregoraszczuk EL. Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line. Pharmacol Rep. 2012; 64(1): 157-65. 8. Zhang L, Wang G, Wang L, Song C, Leng Y, Wang X, Kang J. VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin. Mol Cell Biochem. 2012 Feb; 361(1-2): 39-45. doi:10.1007/s11010-011-1085-x 9. Shan Z, Feng-Nian R, Jie G, Ting Z. Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo. Asian Pac J Cancer Prev. 2012; 13(8): 3977-82. 10. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008 Jan; 9(1): 47-59. doi:10.1038/nrm2308 11. Shuang T, Shi C, Chang S, Wang M, Bai CH. Downregulation of miR-17~92 expression increase paclitaxel sensitivity in human ovarian carcinoma SKOV3-TR30 cells via BIM instead of PTEN. Int J Mol Sci. 2013 Feb; 14(2): 3802-16. doi:10.3390/ijms14023802 12. Vafaiyan Z, Gharaei R, Asadi J. The correlation between telomerase activity and Bax/Bcl-2 ratio in valproic acid-treated MCF-7 breast cancer cell line. Iran J Basic Med Sci. 2015 Jul; 18(7): 700-4. 13. Grabarska A, Dmoszynska-Graniczka M, Jeleniewicz W, Kiebus M, Nowosadzka E, Rivero-Muller A, et al. Valproic acid suppresses growth and enhances cisplatin cytotoxicity to larynx cancer cells. Head Neck Oncol. 2014 May; 6(1): 7. 14. Eun Lee J, Kim HJ. Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1. Genet Mol Biol. 2015 Oct-Dec; 38(4): 527-33. doi:10.1590/S1415-475738420150028 15. Arakawa Y, Saito S, Yamada H, Aiba K. Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-X(L) and promotes apoptosis of MCF-7 breast cancer cells. Apoptosis. 2009 Sep; 14(9): 1076-85. doi:10.1007/s10495-009-0384-0. 16. Phillips A, Bullock T, Plant N. Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO. Toxicology. 2003 Nov; 192(2-3): 219-27. 17. Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss TS, Göttlicher M, et al. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357. J Hepatol. 2005 Feb; 42(2): 210-17. 18. Kaiser M, Zavrski I, Sterz J, Jakob C, Fleissner C, Kloetzel PM, et al. The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma. Haematologica. 2006 Feb; 91(2): 248-51. 19. Tang R, Faussat AM, Majdak P, Perrot JY, Chaoui D, Legrand O, et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. Leukemia. 2004 Jul; 18(7): 1246-51. 20. Angelucci A, Valentini A, Millimaggi D, Gravina GL, Miano R, Dolo V, et al. Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways. Anticancer Drugs. 2006 Nov; 17(10): 1141-50.
|
